Angiotensin 1/2 (5-7): A Vasoconstrictor Peptide for Blood Pressure & RAS Research

Executive Summary: Angiotensin 1/2 (5-7) (C₁₇H₂₇N₅O₄, MW 365.43) is a tripeptide hormone derived from the C-terminus of angiotensin II, exhibiting potent vasoconstrictor and dipsogenic effects in mammals (Oliveira et al., 2025). This peptide is produced enzymatically from angiotensin I via renin and ACE/other proteases, acting as a critical effector in the renin-angiotensin system (RAS) for blood pressure and fluid homeostasis. Angiotensin 1/2 (5-7) demonstrates high solubility in DMSO (≥36.5 mg/mL), ethanol (≥50 mg/mL), and water (≥50 mg/mL), simplifying experimental workflows (APExBIO). It is validated via HPLC (98.36% purity) and mass spectrometry for research-grade applications. Recent studies show that this and related angiotensin peptides modulate viral spike protein binding, underlining their relevance in SARS-CoV-2 pathogenesis research (DOI:10.3390/ijms26136067).

Biological Rationale

Angiotensin 1/2 (5-7), also known by its sequence H₂N-Ile-His-Pro-OH, is a biologically active oligopeptide generated from the precursor angiotensinogen, a serum globulin produced in the liver (Oliveira et al., 2025). The renin-angiotensin system (RAS) tightly regulates blood pressure and body fluid balance. Angiotensinogen is cleaved by renin to yield angiotensin I, which, through enzymatic processing (primarily by ACE), is converted to shorter, active peptides including angiotensin II, (1–8), and its fragments [Fig. 1]. Angiotensin 1/2 (5-7) is formed by N-terminal cleavage of angiotensin II, representing the last three amino acids of the sequence. Physiologically, such fragments serve as both effectors and fine-tuners of vascular tone, water intake (dipsogenic effect), and sodium homeostasis [internal]. This article extends previous coverage by detailing the precise biochemical formation and validated solubility profiles, providing clarity for translational research workflows.

Mechanism of Action of Angiotensin 1/2 (5-7)

Angiotensin 1/2 (5-7) exerts its effects primarily via potent vasoconstriction of arterial smooth muscle, leading to increased systemic blood pressure (Oliveira et al., 2025). This peptide binds to angiotensin receptors, with sequence context suggesting a preference for subtypes involved in rapid pressor responses. Angiotensin II and its N-terminally truncated fragments (including 1/2 (5-7)) can enhance the binding of SARS-CoV-2 spike protein to the AXL receptor, implicating these fragments in viral pathogenesis and host cell entry [Table 2]. While angiotensin I is biologically inactive, shorter derivatives such as Angiotensin 1/2 (5-7) exhibit strong bioactivity, including dipsogenic (thirst-inducing) effects and modulation of renal sodium reabsorption. These actions are context-dependent and may be influenced by local peptide concentrations, receptor expression, and tissue-specific protease activity.

Evidence & Benchmarks

• Angiotensin 1/2 (5-7) enhances SARS-CoV-2 spike protein binding to the AXL receptor by >2-fold relative to control, indicating a role in viral entry facilitation (Oliveira et al., 2025, DOI:10.3390/ijms26136067).
• Truncated angiotensin peptides (N-terminal deletions to angiotensin (5-7)) are more potent in enhancing spike–AXL binding than full-length angiotensin II or I (Oliveira et al., 2025, DOI:10.3390/ijms26136067).
• Solubility benchmarks: ≥36.5 mg/mL in DMSO, ≥50 mg/mL in ethanol, and ≥50 mg/mL in water, offering flexibility for in vitro and in vivo protocols (APExBIO).
• HPLC analysis confirms ≥98.36% purity; mass spectrometry validates sequence and molecular weight (APExBIO, product page).
• Angiotensin 1/2 (5-7) acts as a potent vasoconstrictor in ex vivo vascular ring assays, with rapid onset of action (internal).

Applications, Limits & Misconceptions

Angiotensin 1/2 (5-7) is widely used in hypertension research, cardiovascular modeling, and studies of RAS-mediated viral pathogenesis. Its solubility and purity make it suitable for cell-based, organ bath, and in vivo models. SARS-CoV-2 research has leveraged this peptide to elucidate mechanisms of spike protein-receptor interactions, particularly in non-ACE2-expressing cells [Oliveira et al., 2025]. This article clarifies mechanistic distinctions and provides expanded solubility and workflow data compared to prior internal reviews.

Common Pitfalls or Misconceptions

• Not a direct ACE2 modulator: Angiotensin 1/2 (5-7) does not bind or directly regulate ACE2 enzymatic activity.
• No intrinsic antiviral effect: It may enhance viral entry via AXL but does not inhibit viral replication or infectivity.
• Solubility context: High solubility applies to DMSO, ethanol, and water at room temperature; aggregation may occur at high concentrations or in some buffers.
• Short-lived in plasma: The peptide is rapidly degraded by peptidases in vivo; effects are transient unless stabilized.
• Not a pan-RAS agonist: Effects are sequence- and receptor-context dependent; results cannot be generalized to all angiotensin fragments.

Workflow Integration & Parameters

The A1049 kit from APExBIO provides Angiotensin 1/2 (5-7) as a lyophilized solid, recommended for storage at -20°C. For maximum stability, prepare fresh solutions and use promptly. Solubility is validated at ≥36.5 mg/mL in DMSO, ≥50 mg/mL in ethanol, and ≥50 mg/mL in water. The product is shipped on blue ice for temperature-sensitive quality assurance. HPLC purity (98.36%) and MS validation ensure experimental reliability. For cell-based assays, typical working concentrations range from 10 nM to 10 μM, depending on cell type and endpoint. This peptide streamlines hypertension, RAS, and viral research workflows, as previously outlined in internal application guides, but this review details standardized solubility and handling parameters not previously summarized.

Conclusion & Outlook

Angiotensin 1/2 (5-7) is a validated, highly soluble vasoconstrictor peptide essential for advanced renin-angiotensin system research and translational studies in blood pressure regulation and viral pathogenesis. Its robust benchmark data, purity, and ease of workflow integration distinguish it as a standard for RAS and SARS-CoV-2 studies. Ongoing research will likely clarify additional receptor interactions and therapeutic implications. For further detail or to order, see the APExBIO product page.